CompaniesAnagram Therapeutics
Anagram Therapeutics logo

Anagram Therapeutics

active
Framingham, MA, United States
Founded 2017
Website
About

Inhaled glycopolymer-based therapeutics for the treatment of pulmonary disease

Areas of Focus

Categories

Small Molecule PharmaceuticalDrug Delivery & FormulationBoston & New England
Team (11)
Alexey Margolin, Ph.D.
Anagram Therapeutics
team_member
Andrew W. Miller
Anagram Therapeutics
team_member
David Brown
Anagram Therapeutics
team_member
Don G. Burstyn, Ph.D.
Anagram Therapeutics
team_member
Drucy Borowitz, M.D.
Anagram Therapeutics
team_member
Hugh Wight
Anagram Therapeutics
team_member
View all 11 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

51

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
Today
NCT06052293
Hover over trial bars to see details

Recent Trials

NCT06052293Lead Sponsor
Phase 1 Study to Assess Safety and Efficacy of ANG003
PHASE1Completed
51 participants
Started: Aug 25, 2023 · Completed: Jul 8, 2024
Locations (1)
Headquarters
Framingham, MA, United States
Map

Loading map...